Log In
Print
BCIQ
Print
Print this Print this
 

Cystaran (Cysteamine hydrochloride ophthalmic solution)

  Manage Alerts
Collapse Summary General Information
Company Sigma-Tau Group
DescriptionOphthalmic formulation of cysteamine, a degradation product of the amino acid cysteine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Metabolic (unspecified)
Indication DetailsTreat corneal cystine crystals in patients with cystinosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today